Black Friday Sale - Ends Soon!
-35% Off Everything
Abbott Laboratories (ABT)
Last Price$118.8(0.2%)
Market Cap$196.8B
ABT overview
Crunching data... Almost there!
1W 0.9%
1M 4.7%
6M 19.1%
YTD 10.3%
1Y 16.9%
3Y (1.9%)
5Y 51.6%
10Y 224.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
ABT key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
ABT Intrinsic value
ABT Intrinsic value overview
ABT Historical intrinsic value
ABT Financials
ABT Income statement
Crunching data... Almost there!
ABT Balance sheet
Crunching data... Almost there!
ABT Cash flow statement
Crunching data... Almost there!
ABT Financial ratios
ABT Growth
Crunching data... Almost there!
ABT Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more ABT fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Abbott Laboratories (ABT) stock?
As of today, intrinsic value of Abbott Laboratories is $122.2.
Is Abbott Laboratories (ABT) stock undervalued or overvalued?
As of today, Abbott Laboratories is undervalued by 2.9%, compared to the current market share price of $118.8.
What is Abbott Laboratories (ABT) stock rating?
As of today, Abbott Laboratories has a stock rating of 5 (out of 10), which is considered Good.
is Abbott Laboratories (ABT) a good stock to buy?
As of today, Abbott Laboratories has a Good stock rating, which is 2.9% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.